Shimadzu Corp. Hits Day Low at JPY 3,388 Amid Price Pressure

Shimadzu Corp., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline of 4.74% on May 13, 2026, reaching an intraday low of JPY 3,388.00. This performance stands in contrast to the Japan Nikkei 225, which gained 0.84% on the same day. Over the past week, Shimadzu's stock has decreased by 4.24%, while its monthly performance reflects a more significant drop of 8.38%. Year-to-date, the stock has faced a decline of 16.07%, underperforming the Nikkei 225, which has risen by 25.69%. The company's performance over the last three years shows a decrease of 18.18%, highlighting a consistent trend of underperformance against the benchmark index. Despite these challenges, Shimadzu Corp. maintains a strong management efficiency, evidenced by a return on equity (ROE) of 10.87% and a low debt-to-equity ratio of -0.26. The company has also reported a stable profit increase of 6.9% over the past year, although its stock has generated a return of -2.56%. As of now, Shimadzu's market capitalization stands at JPY 1,137,502 million, reflecting its large-cap status in the industry.